In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

CorMedix Inc. Trade Record

AMEX:CRMD CorMedix Inc stock gains 179.47% Exit Oct 18, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CRMD Sep 20, 2018, priceSeries
About CorMedix Inc

CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and other markets. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Bridgewater, New Jersey.

Trade Information
Trade Type
LONG
ReliabilityScore™
87.38
Entry Date
Sep 20, 2018
Entry Price
3.08
Sell Date
Oct 18, 2018
Sell Price
8.60
Net Gain
179.47%
Hold Time
20 Trading Days